VI. 12 What To Do Now

This closing chapter turns the whole book into action: key takeaways built on four foundations – fiber, sleep, movement, stress management – plus profile-based step lists and a 30-day plan, so you can start with a single step tomorrow.

After eleven chapters, it's worth putting the book down and actually doing something. That's the purpose of this chapter: not new information, but a summary and action guide – by profile. You choose the path that applies to you.

Key takeaways (one page)

The essence of the whole book in 10 sentences:

1. Your microbiome changes every single day – meals, sleep, stress, and movement noticeably affect it within 24–48 hours.
2. Diversity is key. The problem isn't the absence of a single "good" bacterium but a decline in species variety and a disruption of their relative proportions. 30+ plant species per week is the best diversity-improving measure.
3. The disease–microbiota^[G] link sits on four tiers (): recurrent C. difficile is treatable via microbiota-directed therapy (FMT, RCT-grade), but autism or Parkinson's microbiome "modulation" is still hypothesis-level and requires case-by-case consideration. Know where you stand on the evidence map.
4. Nutrition is your strongest lever. Fiber (25–35 g/day), 5+ fermented servings/week, reduced UPF^[G] – these three deliver the most.
5. Sleep, movement, stress combined give 15–25% diversity benefit. Neither substitutes for the others. Consistency > intensity.
6. Probiotics only work indication-specifically. A generic "gut-friendly" pill is not a medication. S. boulardii for AB, B. infantis 35624 for IBS^[G]-D, VSL#3 for pouchitis^[G] – these have strain-level evidence; the rest is just marketing.
7. Antibiotics have the most dramatic microbiome effect of any drug, but when needed they save lives. Distinguishing indicated from unindicated AB is a medical differential-diagnostic task.
8. Most home microbiome tests are acceptable as curiosity but insufficient for clinical decisions. Targeted markers (calprotectin, H. pylori, SIBO^[G] breath test) are worth more in a specialist's hands.
9. Red flags always override everything. Blood in stool, unintentional weight loss, nocturnal symptoms^[G], family history – see a doctor, not self-experimentation. Appendix V (When to See a Doctor) details.
10. The future isn't 1 year – it's 10. The realistic timeline for new microbiota tools entering clinical practice (Vowst^[G], targeted prebiotics, engineered probiotics) is the 2030s. Wait patiently and don't pay premium prices without clinical validation.

Decision algorithm by profile

Four common profiles, each with 5–7 concrete steps.

Profile A: "I'm healthy and want to optimize"

The "I'm fine but want to be better" path. Most cost-effective entry.

Reading order: 4 → 5 → 8 (your life stage) → 2 (if mechanisms interest you)

Concrete steps:

1. One-week diet audit: count how many different plant species you eat in a week. Target: 30+. If under 15, aim for 20 next week.
2. Fiber intake: if under 20 g/day, +5 g per week until reaching 25–35 g.
3. 5+ fermented servings/week: kefir^[G], live-culture yogurt, sauerkraut, kimchi, kombucha. See Appendix III (Food Reference).
4. Sleep window: consistent bed-wake (±30 min, weekends too). 7+ hours target, with as much overlap as possible with the repair window.
5. Movement: a 30-min daily walk or 3× 20 min of moderate intensity per week.
6. Daily 5–10 min breathwork/meditation: morning or before bed. See Appendix IV (Lifestyle Checklists).
7. Optional: start with 12:12 TRE; progress to 14:10 after 2–3 weeks.

What not to do: don't pay for a home microbiome test. Don't start with a "gut-friendly" probiotic^[G] pill. Don't fall into the "detox" trap.

Profile B: "I live with symptoms (bloating, IBS-like, GI complaints)"

The most common profile – and the most often mistreated.

Reading order: 3 (IBS section) → 10 (when to test) → 4 → 11 (probiotic table)

Concrete steps:

1. Red-flag check (Appendix V – When to See a Doctor): blood in stool, weight loss, nocturnal symptoms, family history. If any are yes → urgent gastroenterology, NOT self-experimentation.
2. GP consultation and calprotectin (chapter 10): for IBD^[G] flare^[G] vs. IBS differentiation.
3. If calprotectin is low and IBS-like picture: subtype-matched probiotic for 4–8 week trial (see chapter 11 table). For IBS-D B. infantis 35624, for bloating L. plantarum 299v. If unsuccessful, a microbiota transfer can be attempted.
4. Low-FODMAP^[G] trial with a dietitian (NOT solo – the reintroduction phase matters for microbiome diversity).
5. Consider SIBO breath test if low-FODMAP doesn't improve (chapter 10). The result must be interpreted in context.
6. Stress management (chapter 5) – often weighs as much in IBS as probiotic selection.

What not to do: don't start random probiotics, don't eliminate whole food groups without a clinician, don't do a home microbiome test before GP consult.

Profile C: "I have a diagnosis (IBD, T2DM, IBS, CRC risk, allergy, autoimmune, neurological)"

The profile requiring the most careful planning. Microbiome is adjunct – never a replacement for primary treatment.

Reading order: 3 (your disease group) → 7 (drug interactions) → 11 (therapeutic toolbox) → 4 → Appendix V (When to See a Doctor)

Concrete steps:

1. Read your disease group's evidence level in chapter 3. It tells you what to realistically expect.
2. Treating physician / specialist – coordinate any microbiota-directed step with a microbiota specialist. Don't discontinue prescribed medication on your own.
3. Read chapter 7 for your specific drug's microbiome interactions (PPI, NSAID, metformin^[G], antipsychotic, hormonal, chemotherapy).
4. Specific probiotic only if indication-appropriate (see chapter 11). E.g., E. coli Nissle 1917 or VSL#3 for IBD remission^[G] maintenance – approved by the treating physician.
5. Diet – with a clinical dietitian for IBD, IBS, celiac disease.
6. Lifestyle – sleep, movement, stress (chapter 5) often weigh as much as probiotic.
7. Red-flag monitoring (Appendix V – When to See a Doctor) – living with a diagnosis demands even more vigilance.

What not to do: don't discontinue treatment for a microbiota strategy. Don't try FMT for indications other than C. difficile outside a clinical trial.

Profile D: "I'm coming off an antibiotic course"

The most common acute situation – and the most often mistreated.

Reading order: 7 (recovery protocol) → 11 (probiotic table for AAD) → 4

Concrete steps:

1. During and after AB: S. boulardii CNCM I-745 500 mg/day OR L. rhamnosus GG 10⁹–10¹⁰ CFU/day. Start with AB day 1, continue +3 days after the AB course – only if the AB-induced diarrhea doesn't resolve.
2. Continuous hydration and high-fiber diet (chapter 4) – for microbiota recovery.
3. 5+ fermented servings/week during the 2–6 weeks after the AB course.
4. Stress reduction – AB + infection together impose stress; stress level matters for recovery.
5. Persistent diarrhea 2 weeks after AB? C. difficile test – chapter 7.
6. 6-week post-course clinical review – if symptoms (bloating, irregular bowel) linger.
7. If the patient is a child or elderly, extra attention and pediatrician/geriatrician consult.

What not to do: don't stop the AB course earlier than indicated. Don't start with a generic "gut-friendly" probiotic – strain-specific needed. Don't ignore persistent diarrhea – C. difficile is possible.

Optional 30-day plan

For those wanting structured onboarding, a 4-week sample. Not mandatory – a frame for Profile A or D.

Week 1: What to avoid

• Cut weekly UPF intake by 50%
• Avoid artificial sweeteners (one-week trial)
• Avoid late-night meals (last meal before 19:00)

Week 2: Prebiotic^[G] + fermented

• Introduce 1 fermented serving/day (kefir/yogurt/sauerkraut)
• 3 legume servings/week (beans, lentils, chickpeas)
• Add 5–10 g inulin^[G]/FOS weekly (titrate up)

Week 3: Sleep + stress

• Consistent sleep window
• 1-hour screen reduction before bed
• Daily 5–10 min breathwork
• Weekly nature walk

Week 4: Movement + optional TRE

• 30 min daily walk or 3× moderate-intensity sessions weekly
• Optional 12:12 → 14:10 TRE

New habits only consolidate after 4 weeks; don't quit after the 30-day plan – keep what works.

Continuing the book

Working with material like this is rarely linear: most readers return to specific chapters a few weeks or months later, often triggered by a new symptom, a life-stage milestone, or a clinical consultation. The subsections below mark three moments – when it pays to reread, what to do if you want to go deeper in certain areas, and how to integrate this knowledge into longer-term health decisions. The goal is not to "tick off" the book but to build a reference base you can return to whenever needed.

When to reread

• After a new diagnosis: chapter 3 evidence map, plus your specific disease group
• Before/after antibiotic course: chapters 7 and 11
• Pregnancy, new infant: chapter 8
• Starting a new drug: chapter 7
• Annual review: chapters 1 and 12 – reminder of key takeaways

Further reading

• Appendix II (References) reference list and further reading
• Local and international professional resources (gastroenterology societies, ISAPP)
• Recent research from trustworthy sources (PubMed, ScienceDirect)

Reaching the book's authors

The MicroBiome Bank team continuously updates the book on new evidence. The current version has built a new frame, with the following updates:

• Integration of new RCTs
• Expanded local clinical-practice data
• Clinical validation of next-generation tools (Vowst, HospBiome/DiffBiome, targeted prebiotics) as it becomes available

What you can do tomorrow

Just one thing. Pick one item from the lists above – one food, one habit, one step – and do it tomorrow. The rest can come next week.

Your microbiome will wait until next year. But the good news: if you start one consistent step today, a difference will be measurable by the end of next month.

---

Acknowledgments

The book's three authors (Patay M.D., Bezzegh M.D., Munar M.D.) and the MicroBiome Bank team thank you for reading. A book has value only when its reader actually uses it. If the content helped, share it with those who could benefit.

We openly welcome feedback and questions. This book is a living document – it evolves because science itself evolves.